Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-02 Sale | 2026-10-06 4:35 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $304.07 | $1,520,346 | 60,958 (Direct) | View |
| 2026-09-10 Sale | 2026-09-14 4:59 pm | LIGAND PHARMACEUTICALS INC | LGND | Zimmermann Martine Director | 1,200 | $285 | $342,000 | 3,897 (Direct) | View |
| 2026-09-03 Sale | 2026-09-08 6:34 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $286.09 | $1,430,434 | 36,514 (Direct) | View |
| 2026-08-12 Sale | 2026-08-14 5:05 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 31,641 | $292.06 | $9,241,229 | 27,696 (Direct) | View |
| 2026-08-12 Sale | 2026-08-14 5:04 pm | LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director | 7,138 | $292.81 | $2,090,062 | 3,981 (Direct) | View |
| 2026-08-03 Sale | 2026-08-04 6:42 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $288.99 | $1,444,951 | 70,958 (Direct) | View |
| 2026-07-01 Sale | 2026-07-06 5:11 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $313.28 | $1,566,377 | 76,090 (Direct) | View |
| 2026-06-16 Sale | 2026-06-18 08:37 am | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,145 | $254 | $544,830 | 33,629 (Direct) | View |
| 2026-06-12 Sale | 2026-06-15 9:06 pm | LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director | 6,461 | $255.58 | $1,651,320 | 18,257 (Direct) | View |
| 2026-06-10 Sale | 2026-06-12 5:27 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 5,000 | $250 | $1,250,000 | 118,518 (Indirect Direct) | View |
| 2026-06-10 Sale | 2026-06-12 5:26 pm | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 4,591 | $250.88 | $1,151,774 | 26,969 (Direct) | View |
| 2026-06-01 Sale | 2026-06-02 6:22 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $227.06 | $1,135,316 | 80,826 (Direct) | View |
| 2026-05-01 Sale | 2026-05-14 9:08 pm | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,501 | $225.14 | $563,080 | 43,361 (Direct) | View |
| 2026-05-01 Sale | 2026-05-04 8:20 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $231.31 | $1,156,556 | 85,826 (Direct) | View |
| 2026-04-01 Sale | 2026-04-02 7:43 pm | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 467 | $202.23 | $94,440 | 42,253 (Direct) | View |
| 2026-04-01 Sale | 2026-04-02 6:56 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $201.24 | $1,006,224 | 90,826 (Direct) | View |
| 2026-03-06 Sale | 2026-03-31 5:53 pm | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,161 | $200.76 | $433,842 | 30,724 (Direct) | View |
| 2026-03-23 Sale | 2026-03-25 11:13 am | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 1,000 | $207.87 | $207,873 | 32,793 (Direct) | View |
| 2026-03-11 Sale | 2026-03-13 7:29 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 3,057 | $225 | $687,825 | 21,010 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 6:51 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $206.35 | $1,031,770 | 91,313 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 6:49 pm | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 13,423 | $205.83 | $2,762,822 | 21,662 (Direct) | View |
| 2026-03-03 Sale | 2026-03-05 11:05 am | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,034 | $201.5 | $409,851 | 33,793 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 9:04 pm | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 467 | $200.5 | $93,632 | 42,720 (Direct) | View |
| 2026-02-02 Sale | 2026-02-04 5:18 pm | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 467 | $195.91 | $91,490 | 43,187 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-02 Exercise | 2026-10-06 4:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 340 | $52.27 | 60,958 (Direct) | View |
| 2026-10-02 Exercise | 2026-10-06 4:35 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 340 | $0 | 60,958 (Direct) | View |
| 2026-09-22 Tax Withholding | 2026-09-24 5:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Zimmermann Martine Director | 115 | $298.5 | 3,782 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 5:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 7,171 | $57.22 | 27,696 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 5:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 3,348 | $68.74 | 27,696 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 5:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 16,179 | $52.84 | 27,696 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 5:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 2,074 | $70.04 | 27,696 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 5:05 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 31,641 | $0 | 27,696 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 5:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 2,869 | $55.75 | 27,696 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 5:04 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director | 6,138 | $51.56 | 3,981 (Direct) | View |
| 2026-08-12 Exercise | 2026-08-14 5:04 pm | N/A 2032-06-29 | LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director | 6,138 | $0 | 3,981 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-04 6:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $52.27 | 70,958 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-04 6:42 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $0 | 70,958 (Direct) | View |
| 2026-06-30 Other | 2026-07-06 5:11 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 132 | $160.71 | 76,090 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-06 5:11 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $52.27 | 76,090 (Direct) | View |
| 2026-07-01 Exercise | 2026-07-06 5:11 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $0 | 76,090 (Direct) | View |
| 2026-06-30 Other | 2026-07-06 5:11 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 17 | $160.71 | 27,713 (Direct) | View |
| 2026-06-30 Other | 2026-07-06 5:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 132 | $160.71 | 199,645 (Direct) | View |
| 2026-06-16 Exercise | 2026-06-18 08:37 am | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,145 | $66.13 | 33,629 (Direct) | View |
| 2026-06-16 Exercise | 2026-06-18 08:37 am | N/A 2027-05-25 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,145 | $0 | 33,629 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-15 9:06 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director | 4,000 | $51.56 | 18,257 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-15 9:06 pm | N/A 2032-06-29 | LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director | 4,000 | $0 | 18,257 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-12 5:27 pm | N/A 2036-06-05 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 3,774 | $0 | 118,518 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-09 7:42 pm | N/A 2036-06-05 | LIGAND PHARMACEUTICALS INC | LGND | Zimmermann Martine Director | 3,774 | $0 | 8,035 (Direct) | View |
| 2026-06-05 Tax Withholding | 2026-06-09 7:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Zimmermann Martine Director | 182 | $237 | 8,035 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-09 7:41 pm | N/A 2036-06-05 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 3,774 | $0 | 36,567 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-09 7:41 pm | N/A 2036-06-05 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 3,774 | $0 | 34,498 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-09 7:40 pm | N/A 2036-06-05 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 3,774 | $0 | 45,560 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-09 7:35 pm | N/A 2036-06-05 | LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director | 3,774 | $0 | 10,380 (Direct) | View |
| 2026-06-05 Option Award | 2026-06-09 7:35 pm | N/A 2036-06-05 | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 3,774 | $0 | 11,868 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-02 6:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $52.27 | 80,826 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-02 6:22 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $0 | 80,826 (Direct) | View |
| 2026-05-27 Exercise | 2026-05-28 7:43 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 972 | $52.84 | 45,086 (Direct) | View |
| 2026-05-27 Exercise | 2026-05-28 7:43 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,736 | $0 | 45,086 (Direct) | View |
| 2026-05-27 Exercise | 2026-05-28 7:43 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 764 | $63.62 | 45,086 (Direct) | View |
| 2026-05-12 Exercise | 2026-05-14 9:08 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,034 | $69.51 | 43,361 (Direct) | View |
| 2026-05-12 Exercise | 2026-05-14 9:08 pm | N/A 2026-05-23 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,034 | $0 | 43,361 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-04 8:20 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $52.27 | 85,826 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-04 8:20 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $0 | 85,826 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 6:56 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $52.27 | 90,826 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-02 6:56 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $0 | 90,826 (Direct) | View |
| 2026-03-06 Exercise | 2026-03-31 5:53 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,161 | $114.15 | 30,724 (Direct) | View |
| 2026-03-06 Exercise | 2026-03-31 5:53 pm | N/A 2028-06-19 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,161 | $0 | 30,724 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-27 9:20 pm | N/A 2036-03-02 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 28,460 | $0 | 61,472 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-27 8:33 pm | N/A 2036-03-02 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 60,553 | $0 | 249,439 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-27 8:16 pm | N/A 2036-03-02 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 26,038 | $0 | 62,907 (Direct) | View |
| 2026-03-11 Exercise | 2026-03-13 7:29 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 2,405 | $92.65 | 21,010 (Direct) | View |
| 2026-03-11 Exercise | 2026-03-13 7:29 pm | N/A 2028-03-02 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 2,405 | $0 | 21,010 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 6:51 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $52.27 | 91,313 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 6:51 pm | N/A 2032-08-01 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 5,000 | $0 | 91,313 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 6:49 pm | N/A 2027-02-24 | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 2,073 | $0 | 21,662 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 6:49 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 466 | $80.72 | 21,662 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 6:49 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 1,607 | $58.49 | 21,662 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 11:05 am | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,034 | $69.51 | 33,793 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 11:05 am | N/A 2026-05-23 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,034 | $0 | 33,793 (Direct) | View |
| 2026-02-14 Option Award | 2026-02-18 4:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 15,738 | $0 | 36,869 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CLO & Secretary | 9,680 | $183.83 | 36,869 (Direct) | View |
| 2026-02-14 Option Award | 2026-02-18 4:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 16,200 | $0 | 33,012 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer | 11,763 | $183.83 | 33,012 (Direct) | View |
| 2026-02-14 Option Award | 2026-02-18 4:21 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 60,426 | $0 | 188,886 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:21 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer | 32,877 | $183.83 | 188,886 (Direct) | View |